Vir Biotech Shuns FDA Submission Plans For GSK-Partnered COVID-19 Treatment
Aug 10th, 2022 7:35 EST
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.